Japan is considering approving the use of the COVID-19 vaccine developed by Britain's AstraZeneca Plc for people aged 18 or over, sources close to the matter said Wednesday.The Ministry of Health, Labor and Welfare granted fast-track approval for the vaccine in May but indicated at the time that it did not intend to use the vaccine immediately due to rare cases of blood clots reported overseas.It is already planning to approve the AstraZeneca vaccine for people aged 60 or older, other sources said earlier.An expert panel of the health ministry will discuss the eligible age range for the vac…READ FULL ARTICLE